Literature DB >> 6978962

Circulating vitamin D metabolite concentrations in childhood renal diseases.

R W Chesney, A J Hamstra, R B Mazess, P Rose, H F DeLuca.   

Abstract

Vitamin D metabolites were measured in children, untreated with glucocorticoids, who had renal disease. Two groups were defined in relation to endogenous creatinine clearance values: those with impaired clearance , 0 to 48 ml/min per 1.73 m2; and those with unimpaired clearance, 75 to 150 ml/min per 1.73 m2. Serum 1.25(OH)2D was 16 +/- (SD) 12 pg/ml in impaired patients (N=24) and 48 +/- 16 pg/ml in unimpaired patients (N=18). The latter level is not different from healthy childhood controls (43 +/- 12 pg/ml; N=194). Serum samples of 25(OH)D2 and D3 were comparable in each group and not different from control values of 33.2 +/- 10.3 ng/ml. Serum 24,25(OH)2D was 0.6 +/- (SD) 0.14 ng/ml in patients with a clearance of less than 13 ml/min per 1.73 m2, 1.39 +/- 0.54 ng/ml in those with a clearance of 18 to 48 ml/min per 1.73 m2, and 152 +/- 0.91 ng/ml in patients without an impairment of clearance. Only patients with the lowest clearance had values different from control values of 1.70 +/- 0.57 ng/ml. In our study we suggest that a significant reduction in 24,25(OH)2D and 1,25(OH)2D are found at low clearance values in children with tubulointerstitial disease. Our study further suggests that a reduction in renal tubular mass is important in accounting for these changes in vitamin D metabolite values.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978962     DOI: 10.1038/ki.1982.9

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Recent developments in vitamin D metabolism and its clinical application for renal disease.

Authors:  R W Chesney
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

2.  Cystinosis and vitamin D.

Authors:  R Steinherz
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

3.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 4.  Recent advances and controversies in childhood renal osteodystrophy.

Authors:  O Mehls; I B Salusky
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

5.  Vitamin D metabolite profiles in moderate renal insufficiency of childhood.

Authors:  A Taylor; M E Norman
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

6.  Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.

Authors:  Norikazu Toi; Masaaki Inaba; Eiji Ishimura; Naoko Tsugawa; Yasuo Imanishi; Masanori Emoto; Yoshiaki Hirayama; Shinya Nakatani; Akihiko Saito; Shinsuke Yamada
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

7.  Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.

Authors:  Wai W Cheung; Sheng Hao; Zhen Wang; Wei Ding; Ronghao Zheng; Alex Gonzalez; Jian-Ying Zhan; Ping Zhou; Shiping Li; Mary C Esparza; Hal M Hoffman; Richard L Lieber; Robert H Mak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-11-13       Impact factor: 12.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.